In this month’s Q&A, Big Ten Cancer Research Consortium (Big Ten CRC) Administrative Headquarters addresses common questions related to correlative research.
In what aspects of a clinical trial are correlative research managers at Big Ten CRC Administrative Headquarters able to assist?
As clinical trials continue to increase in complexity and further emphasize translational science, the collection of correlative specimens and the succeeding specimen analysis becomes ever more important. Read More
Jan. 19, 2015: We begin a new year with recent highlights from each member institution of the Big Ten Cancer Research Consortium. From new discoveries in our understanding of RNAs to re-emerging ideas about Vitamin C; from initiatives that focus on our communities at home to those that stretch across continents, Big Ten cancer centers continue to innovate and inspire. Here’s to a promising new year across the consortium! Read More
Jan. 1, 2015:A conversation with Robert A. Winn, MD, interim director of the University of Illinois Cancer Center, which is a member of the Big Ten Cancer Research Consortium.Q: What kind of impact do you see the Big Ten Cancer Research Consortium having on cancer clinical trials? On our own, we each have characteristics that demonstrate who we are individually and in the context of our institution. In the context of the Big Ten CRC, our consortium harnesses the clinical expertise of 12 leading cancer centers specifically related to breast, GI, GU, GYN, hematologic, melanoma, and thoracic malignancies. Additionally, this is a fascinating time to be conducting cancer clinical trials:... Read More
Dec. 31, 2014: As the year comes to a close, the Big Ten Cancer Research Consortium would like to thank each of our member institutions for making 2014 a year of outstanding accomplishments. Hard work and a spirit of collaboration have underscored a number of significant milestones that are worthy of celebration. Consider just a few examples of what we have accomplished together: Read More
Dec. 17, 2014: Big Ten cancer centers are making tremendous strides in tackling some of the toughest questions in cancer research. In this month's edition of "Across the Consortium," we highlight advances in leukemia, prostate cancer, ovarian cancer, lung cancer, and new technologies and discoveries that could improve outcomes across many cancers. Behind these advances in research at Big Ten cancer centers are academic physicians and scientists who are not only brilliant in their fields, but also committed to patient advocacy and disease prevention. Here are a few recent highlights across the consortium: Read More
Dec. 4, 2014: In this month's Q&A, Big Ten Cancer Research Consortium (Big Ten CRC) Administrative Headquarters addresses common questions related to regulatory and safety. What are the responsibilities of Big Ten CRC regulatory managers? Big Ten CRC regulatory managers assist with all aspects of regulatory issues related to Big Ten CRC research, including interactions with consortium members, institutional review boards, and regulatory agencies. Regulatory services include: Read More
Dec. 1, 2014:A conversation with George Weiner, MD, director of Holden Comprehensive Cancer Center at the University of Iowa and the C.E. Block Chair of Cancer Research and professor of internal medicine at the University of Iowa. Dr. Weiner has led a statewide collaborative to reduce the burden of cancer in Iowa, served on committees within the National Cancer Institute, and just began a two-year term as president of the Association of American Cancer Institutes (AACI), which comprises 92 leading cancer research centers in the United States.Q: What kind of impact do you see the Big Ten Cancer Research Consortium having on cancer clinical trials? Every one of our institutions has an outstanding group... Read More
Nov. 14, 2014: Today, the Big Ten Cancer Research Consortium introduces a new monthly feature highlighting news from our member institutions. We are proud to highlight each of our members, as we work together to improve the lives of all patients with cancer. Several Big Ten CRC member institutions were profiled in US Airways Magazine’s October issue in an extensive feature on the Association of American Cancer Institutes. The featured institutions include the University of Illinois Cancer Center, the University of Iowa Holden Comprehensive Cancer Center, the Read More
Nov. 1, 2014:A conversation with Douglas Yee, MD, director of the Masonic Cancer Center, which is a member of the Big Ten Cancer Research Consortium.Q: What strengths does the Masonic Cancer Center bring to the consortium? At the University of Minnesota and at the Masonic Cancer Center, there is a very collaborative atmosphere. We act collectively with the goal to change cancer outcomes, versus looking to finish a task solely on our own. The leadership here will bend over backwards to help each other because that ultimately helps patients. For example, I work mainly on breast cancer, and a colleague of mine focuses on HIV. He has studied mechanisms of... Read More
Oct. 1, 2014:What are the responsibilities of Big Ten CRC project managers? Big Ten CRC project managers coordinate and supervise the clinical trial from concept to close out. They serve as the main point of contact with pharmaceutical companies, physicians, and site staff. Project managers train all study staff on each protocol through a Site Initiation Visit (SIV). They also create and maintain a Study Procedures Manual (SPM) for each study. Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube